What is Voicebrook?
Voicebrook operates at the intersection of clinical pathology and software engineering, providing essential reporting solutions such as VoiceOver PRO and SynoptIQ eCP. The company addresses critical pain points in anatomic pathology by automating documentation workflows and ensuring strict adherence to CAP eCP standards. By integrating directly into existing laboratory information systems, Voicebrook enables pathology departments to mitigate transcription errors and accelerate turnaround times. This focus on high-fidelity reporting tools positions the company as a vital partner for healthcare institutions aiming to optimize diagnostic precision and patient care outcomes through digital transformation.
How much funding has Voicebrook raised?
Voicebrook has raised a total of $2.2M across 2 funding rounds:
Debt
$1M
Debt
$1.2M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.2M led by PPP
Key Investors in Voicebrook
PPP
Public-Private Partnership
What's next for Voicebrook?
With the recent influx of capital, Voicebrook is well-positioned to scale its enterprise-level operations and expand its footprint within the pathology diagnostics market. The strategic focus will likely center on enhancing the interoperability of its software ecosystem and deepening the analytical capabilities of its reporting platforms. As the demand for standardized, error-free pathology documentation grows, Voicebrook is expected to leverage its financial runway to accelerate product development cycles and strengthen its competitive advantage. Future growth initiatives will likely prioritize the integration of advanced diagnostic workflows, further cementing the company's role as a foundational technology provider for modern pathology labs seeking to improve efficiency and clinical reliability.
See full Voicebrook company page
